Cover ImageSALE
Market Research Report

Global Cardiac Rhythm Management (CRM) Devices Market 2017-2021

Published by TechNavio (Infiniti Research Ltd.) Product code 201518
Published Content info 84 Pages
Immediate Delivery Available
Price
Back to Top
Global Cardiac Rhythm Management (CRM) Devices Market 2017-2021
Published: October 12, 2017 Content info: 84 Pages
Description

About Cardiac Rhythm Management (CRM) Devices

CRM devices are used for treating all the major heart conditions such as coronary artery disease (CAD), stroke, cardiac arrest, and arrhythmia. The global CRM devices market is increasing owing to the rising prevalence of CVDs, increasing uptake of MCT, and growing patient awareness. There are three types of CRM devices available such as defibrillators, pacemakers, and CRT devices. The global pacemakers market will grow at a rapid pace followed by defibrillators and CRT devices. By geography, the Americas, EMEA, and APAC will showcase rapid growth rate during the forecast period. APAC will grow at the fastest pace during the forecast period followed by EMEA and the Americas.

Technavio's analysts forecast the global cardiac rhythm management (CRM) devices market to grow at a CAGR of 7.64% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac rhythm management (CRM) devices market for 2017-2021. To calculate the market size, the report considers the total sales volume and the revenue generated from it.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cardiac Rhythm Management (CRM) Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • Boston Scientific
  • Medtronic

Other Prominent Vendors

  • BIOTRONIK
  • Cardiac Science
  • CCC Medical Devices (acquired by Greatbatch)
  • Cook Medical
  • GE Healthcare
  • Integer
  • Mortara Instrument (acquired by Hill-Rom Holdings)
  • Neovasc
  • Philips Healthcare
  • Physio-Control (Subsidiary of Stryker)
  • Rochling Medical
  • Schiller
  • LivaNova
  • ZOLL Medical

Market driver

  • Rising incidence of CVDs
  • For a full, detailed list, view our report

Market challenge

  • Dearth of skilled healthcare professionals*
  • For a full, detailed list, view our report

Market trend

  • Technological advances
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR15494

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline

PART 05: MARKET LANDSCAPE

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Defibrillators - market size & forecast
  • Pacemakers - market size & forecast
  • CRT devices - market size & forecast
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY END-USER

  • Hospitals
  • ASCs
  • Physicians' clinics

PART 08: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - market size & forecast
  • EMEA - market size & forecast
  • APAC - market size & forecast
  • Market opportunity

PART 09: DECISION FRAMEWORK

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Competitive scenario
  • Other prominent vendors

PART 12: VENDOR ANALYSIS

  • Vendor overview
  • Abbott
  • Boston Scientific
  • Medtronic

PART 13: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 02: Global CRM devices market
  • Exhibit 03: Market overview of CRM devices (2017-2021)
  • Exhibit 04: Global CRM devices market 2016-2021 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Product - market size & forecast
  • Exhibit 07: Comparison by Product
  • Exhibit 08: Defibrillators - Market size & forecast ($ billions)
  • Exhibit 09: Defibrillators - Year-over-year growth (%)
  • Exhibit 10: Pacemakers - Market size & forecast ($ billions)
  • Exhibit 11: Pacemakers - Year-over-year growth (%)
  • Exhibit 12: CRT devices- Market size & forecast ($ billions)
  • Exhibit 13: CRT devices - Year-over-year growth (%)
  • Exhibit 14: Global - market size & forecast
  • Exhibit 15: Regional comparison
  • Exhibit 16: Americas - market size & forecast ($ billions)
  • Exhibit 17: Prevalence of vascular diseases in US
  • Exhibit 18: Americas - Year-over-year growth (%)
  • Exhibit 19: Top 2 countries in Americas
  • Exhibit 20: EMEA - market size & forecast ($ billions)
  • Exhibit 21: EMEA - Year-over-year growth (%)
  • Exhibit 22: Top 2 countries in EMEA
  • Exhibit 23: APAC - market size & forecast ($ billions)
  • Exhibit 24: APAC - Year-over-year growth (%)
  • Exhibit 25: Top 2 countries in APAC
  • Exhibit 26: Competitive structure analysis of global CRM devices market 2016
  • Exhibit 27: Abbott: Key highlights
  • Exhibit 28: Abbott: Strength assessment
  • Exhibit 29: Abbott: Strategy assessment
  • Exhibit 30: Abbott: Opportunity assessment
  • Exhibit 31: Boston Scientific: Key highlights
  • Exhibit 32: Boston Scientific: Strength assessment
  • Exhibit 33: Boston Scientific: Strategy assessment
  • Exhibit 34: Boston Scientific: Opportunity assessment
  • Exhibit 35: Medtronic: Revenue by product segment 2017
  • Exhibit 36: Medtronic: Key highlights
  • Exhibit 37: Medtronic: Strength assessment
  • Exhibit 38: Medtronic: Strategy assessment
  • Exhibit 39: Medtronic: Opportunity assessment
Back to Top